Literature DB >> 16273546

Modulation of excitatory synaptic transmission by endogenous glutamate acting on presynaptic group II mGluRs in rat substantia nigra compacta.

Lie Wang1, Stephen T Kitai, Zixiu Xiang.   

Abstract

Excitatory synaptic inputs from the subthalamic nucleus (STN) have been proposed to underlie burst firing of substantia nigra pars compacta (SNc) dopamine (DA) neurons in Parkinson's disease. Given the potential importance of the STN-SNc synapse in health and disease, our goal was to study how transmission at this synapse is regulated. We tested the hypothesis that neurotransmission at STN-SNc synapses is tonically inhibited by endogenous glutamate acting on presynaptic group II metabotropic glutamate receptors (mGluRs). By using whole-cell recording techniques in brain slices, we examined the effect of LY341495, a mGluR antagonist that is most potent at group II mGluRs, on excitatory postsynaptic currents (EPSCs) that either were evoked in SNc DA neurons by stimulation of the STN or were spontaneously occurred in the presence of tetrodotoxin (miniature EPSCs; mEPSCs). LY341495 increased the evoked EPSC amplitude and mEPSC frequency without changing mEPSC amplitude. In contrast, the group III mGluR antagonist UBP1112 failed to increase the evoked EPSC amplitude. An elevation of extracellular glutamate concentration by a glutamate transporter inhibitor, TBOA, suppressed the evoked EPSCs. LY341495, but not UBP1112, partially reversed the TBOA action. The modulations of EPSCs by TBOA and LY341495 were associated with changes in paired-pulse facilitation ratio. Furthermore, TBOA decreased mEPSC frequency, which was partially reversed by LY341495, without affecting mEPSC amplitude. The results indicate that presynaptic group II mGluRs at STN-SNc synapses appear to be partially activated by a basal level of extracellular glutamate and able to sense the change in extracellular glutamate concentration, subsequently modulating synaptic glutamate release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16273546     DOI: 10.1002/jnr.20694

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

1.  Activation of synaptic group II metabotropic glutamate receptors induces long-term depression at GABAergic synapses in CNS neurons.

Authors:  Zheng-Quan Tang; Yu-Wei Liu; Wei Shi; Emilie Hoang Dinh; William R Hamlet; Rebecca J Curry; Yong Lu
Journal:  J Neurosci       Date:  2013-10-02       Impact factor: 6.167

2.  Regulation of cocaine-induced reinstatement by group II metabotropic glutamate receptors in the ventral tegmental area.

Authors:  Lianyi Lu; Yueqiang Xue; Jeffery D Steketee; George V Rebec; Wenlin Sun
Journal:  Psychopharmacology (Berl)       Date:  2011-09-01       Impact factor: 4.530

3.  Target-cell-specific Short-term Plasticity Reduces the Excitatory Drive onto CA1 Interneurons Relative to Pyramidal Cells During Physiologically-derived Spike Trains.

Authors:  Hua Yu Sun; Qin Li; Aundrea F Bartley; Lynn E Dobrunz
Journal:  Neuroscience       Date:  2018-08-10       Impact factor: 3.590

4.  The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine.

Authors:  Yonatan M Kupchik; Khaled Moussawi; Xing-Chun Tang; Xiusong Wang; Benjamin C Kalivas; Rosalia Kolokithas; Katelyn B Ogburn; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2011-12-03       Impact factor: 13.382

5.  Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease.

Authors:  Jonathan W Dickerson; P Jeffrey Conn
Journal:  Neurodegener Dis Manag       Date:  2012-04-01

Review 6.  Glutamate receptors as therapeutic targets for Parkinson's disease.

Authors:  Kari A Johnson; P Jeffrey Conn; Colleen M Niswender
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

Review 7.  Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  Curr Opin Pharmacol       Date:  2018-03-30       Impact factor: 5.547

8.  Interaction between Ephrins and mGlu5 metabotropic glutamate receptors in the induction of long-term synaptic depression in the hippocampus.

Authors:  Sonia Piccinin; Carlo Cinque; Laura Calò; Gemma Molinaro; Giuseppe Battaglia; Laura Maggi; Ferdinando Nicoletti; Daniela Melchiorri; Fabrizio Eusebi; Peter V Massey; Zafar I Bashir
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

9.  Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease.

Authors:  Hugh Chan; Helen Paur; Anthony C Vernon; Virginia Zabarsky; Krishna P Datla; Martin J Croucher; David T Dexter
Journal:  Parkinsons Dis       Date:  2010-05-23

10.  Quantal glutamate release is essential for reliable neuronal encodings in cerebral networks.

Authors:  Jiandong Yu; Hao Qian; Na Chen; Jin-Hui Wang
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.